ABOS vs LYB · $73.3M cap vs P/E 21, rev $16.37B
Acumen Pharmaceuticals Inc (ABOS) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
ABOS does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
ABOS currently screens at market cap $73.3M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the ABOS and LYB stock pages for the full models.
Not investment advice.